Skip to main content
Log in

Effects of a proton pump inhibitor, omeprazole, on gastric secretion and gastric and duodenal ulcers or erosions in rats

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The effects of omeprazole, a proton pump inhibitor, on gastric secretion and gastric or duodenal ulcers or erosions in rats were studied. Omeprazole, given intraduodenally, dose-dependently inhibited the gastric secretion (volume, acid and pepsin output) of pylorus-ligated rats. The antisecretory activity of omeprazole at 100 mg/kg persisted for 14 hr after treatment. Acutely induced gastric ulcers or erosions such as Shay ulcers, water-immersion stress-, indomethacin-, aspirin-, or prednisolone-induced erosions were all markedly inhibited by oral or intraduodenal administration of 10–100 mg/kg of omeprazole. The development of duodenal ulcers and gastric erosions caused by mepirizole was also potently inhibited by omeprazole at 3–10 mg/kg given orally. Repeated administration of omeprazole, 200 mg/kg/day in two divided doses for 14 days, significantly accelerated the spontaneous healing of acetic acid-induced gastric ulcers. The mechanism by which omeprazole inhibits the development of acute ulcers and accelerates healing of preexisting ulcers appears to be mainly due to its potent and longlasting antisecretory activity. The antisecretory and antiulcer activities of omeprazole are equal to or exceed those of cimetidine, both in the maximum inhibitory response and ED50 values.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sundell G, Sjöstrand SE, Olbe L: Gastric antisecretory effects of H 83/69, a benzimidazolyl-pyridylmethyl-sulphoxide. Acta Pharmacol Toxicol 41(Suppl):77, 1977

    Google Scholar 

  2. Fellenius E, Berglindh T, Sachs G, Olbe L, Elander B, Sjöstrand SE, Wallmark B: Substituted benzimidazoles inhibit gastric acid secretion by blocking (H++K+)ATPase. Nature 290:159–161, 1981

    Google Scholar 

  3. Olbe L, Haglund U, Leth R, Lind T, Cederberg C, Ekenved G, Elander B, Fellenius E, Lundborg P, Wallmark B: Effects of substituted benzimidazole (H 149/94) on gastric acid secretion in humans. Gastroenterology 83:193–198, 1982

    Google Scholar 

  4. Fellenius E, Elander B, Wallmark B, Helander HF, Berglindh T: Inhibition of acid secretion in isolated gastric glands by substituted benzimidazoles. Am J Physiol 243:505–510, 1982

    Google Scholar 

  5. Lind T, Cederberg C, Ekenved G, Haglund U, Olbe L: Effect of omeprazole-a gastric proton pump inhibitor-on pentagastrin stimulated acid secretion in man. Gut 24:270–276, 1983

    Google Scholar 

  6. Anson ML: The estimation of pepsin, trypsin, papain and cathepsin with hemoglobin. J Gen Physiol 22:79–89, 1938

    Google Scholar 

  7. Takagi K, Okabe S: The effects of drugs on the production and recovery processes of the stress ulcer. Jpn J Pharmacol 18:9–18, 1968

    Google Scholar 

  8. Takagi K, Kasuya Y, Watanabe K: Studies of the drugs for peptic ulcer, a reliable method for producing stress ulcer in rats. Chem Pharm Bull 12:465–472, 1964

    Google Scholar 

  9. Shay H, Komarov SA, Fels SS, Meranze D, Gruenstein M, Siplet H: A simple method for the uniform production of gastric ulceration in the rat. Gastroenterology 5:43–61, 1945

    Google Scholar 

  10. Kasuya Y, Urushidani T, Okabe S: Effects of various drugs and vagotomy on indomethacin-induced gastric ulcers in the rat. Jpn J Pharmacol 29:670–673, 1979

    Google Scholar 

  11. Okabe S, Takeuchi K, Nakamura K, Takagi K: Pathogenesis of gastric lesions induced by aspirin in the pylorus-ligated rat. Jpn J Pharmacol 24:363–371, 1974

    Google Scholar 

  12. Robert A, Nezamis JE: Ulcerogenic property of steroids. Proc Soc Exp Biol Med 99:443–447, 1958

    Google Scholar 

  13. Okabe S, Ishihara Y, Inoo H, Tanaka H: Mepirizole-induced duodenal ulcers in rats and their pathogenesis. Dig Dis Sci 27:242–249, 1982

    Google Scholar 

  14. Takagi K, Okabe S, Saziki R: A new method for the production of chronic gastric ulcer in rats and the effect of several drugs on its healing. Jpn J Pharmacol 19:418–426, 1969

    Google Scholar 

  15. Litchfield JT, Wilcoxon F: A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99–113, 1949

    Google Scholar 

  16. Lind T, Cederberg C, Ekenved G, Haglund U, Olbe L: The duration of the inhibitory effect of omeprazole on gastric acid secretion in healthy subjects. Scand J Gastroenterol 17(Suppl):14, 1982

    Google Scholar 

  17. Larsson H, Carlsson E, Junggren U, Olbe L, Sjostrand SE, Sundell G: Animal studies with omeprazole, a potent inhibitor of gastric acid secretion. Scand J Gastroenterol 17(Suppl):76, 1982

    Google Scholar 

  18. Mattsson H, Andersson K, Larsson H: Omeprazole provides protection against experimentally induced gastric mucosal lesions. Eur J Pharmacol 91:111–114, 1983

    Google Scholar 

  19. Kitagawa H, Fujiwara M, Osumi Y: Effects of waterimmersion stress on gastric secretion and mucosal blood flow in rats. Gastroenterology 77:298–302, 1979

    Google Scholar 

  20. Watanabe K: Some pharmacological factors involved in formation and prevention of stress ulcer in rats. Chem Pharm Bull 14:101–107, 1966

    Google Scholar 

  21. Yano S, Akahane M, Harada M: Role of gastric motility in development of stress-induced gastric lesions of rats. Jpn J Pharmacol 28:607–615, 1978

    Google Scholar 

  22. Okabe S, Takeuchi K, Kunimi H, Kanno M, Kawashima M: Effects of an antiulcer drug, sucralfate (a basic aluminum salt of sulfated disaccharide), on experimental gastric lesions and gastric secretion in rats. Dig Dis Sci 28:1034–1042, 1983

    Google Scholar 

  23. Ishibashi A, Kasuya Y, Takeuchi K, Okabe S: Effects of 15 (S), 15-methyl-PGE2 methyl ester on healing of chronic gastric and duodenal ulcers in rats. Jpn J Pharmacol 29:807–810, 1979

    Google Scholar 

  24. Valcavi U, Caponi R, Brambilla A, Palmira M, Minoja F, Bernini F, Musanti R, Fumagalli R: Gastric antisecretory, antiulcer and cytoprotective properties of 9-hydroxy-19,20-bis-nor-prostanoic acid in experimental animals. Arzneim Forsch 32:657–663, 1982

    Google Scholar 

  25. Nagashima R, Hirano T: Selective binding of sucralfate to ulcer lesion. I. Experiments in rats with acetic acid-induced gastric ulcer receiving unlabelled sucralfate. Arzneim Forsch 30:80–83, 1980

    Google Scholar 

  26. Nagashima R, Hinohara Y, Hirano Y, Tohira Y, Kamiyama H: Selective binding of sucralfate to ulcer lesion. II. Experiments in rats with gastric ulcer receiving14C-sucralfate or potassium14C-sucrose sulfate. Arzneim Forsch 30:84–88, 1980

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamamoto, O., Okada, Y. & Okabe, S. Effects of a proton pump inhibitor, omeprazole, on gastric secretion and gastric and duodenal ulcers or erosions in rats. Digest Dis Sci 29, 394–401 (1984). https://doi.org/10.1007/BF01296212

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01296212

Keywords

Navigation